218 related articles for article (PubMed ID: 24439148)
21. Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration.
Xie X; Wang Y; Zhao C; Guo S; Liu S; Jia W; Tuan RS; Zhang C
Biomaterials; 2012 Oct; 33(29):7008-18. PubMed ID: 22818985
[TBL] [Abstract][Full Text] [Related]
22. Adipose-derived mesenchymal cells as a potential cell source for skeletal regeneration.
Xu Y; Malladi P; Wagner DR; Longaker MT
Curr Opin Mol Ther; 2005 Aug; 7(4):300-5. PubMed ID: 16121695
[TBL] [Abstract][Full Text] [Related]
23. Making Them Commit: Strategies to Influence Phenotypic Differentiation in Mesenchymal Stem Cells.
Giai Via A; McCarthy MB; de Girolamo L; Ragni E; Oliva F; Maffulli N
Sports Med Arthrosc Rev; 2018 Jun; 26(2):64-69. PubMed ID: 29722765
[TBL] [Abstract][Full Text] [Related]
24. Repairing damaged tendon and muscle: are mesenchymal stem cells and scaffolds the answer?
Davies BM; Morrey ME; Mouthuy PA; Baboldashti NZ; Hakimi O; Snelling S; Price A; Carr A
Regen Med; 2013 Sep; 8(5):613-30. PubMed ID: 23998754
[TBL] [Abstract][Full Text] [Related]
25. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
Yi T; Song SU
Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
[TBL] [Abstract][Full Text] [Related]
26. [Stem cells in orthopaedics].
Neckař P; Syková E
Cas Lek Cesk; 2015; 154(3):107-9. PubMed ID: 26311024
[TBL] [Abstract][Full Text] [Related]
27. Cell proliferation, viability, and in vitro differentiation of equine mesenchymal stem cells seeded on bacterial cellulose hydrogel scaffolds.
Favi PM; Benson RS; Neilsen NR; Hammonds RL; Bates CC; Stephens CP; Dhar MS
Mater Sci Eng C Mater Biol Appl; 2013 May; 33(4):1935-44. PubMed ID: 23498215
[TBL] [Abstract][Full Text] [Related]
28. Cell therapies for tendons: old cell choice for modern innovation.
Petrou IG; Grognuz A; Hirt-Burri N; Raffoul W; Applegate LA
Swiss Med Wkly; 2014; 144():w13989. PubMed ID: 25102358
[TBL] [Abstract][Full Text] [Related]
29. Stem cells in veterinary medicine--attempts at regenerating equine tendon after injury.
Richardson LE; Dudhia J; Clegg PD; Smith R
Trends Biotechnol; 2007 Sep; 25(9):409-16. PubMed ID: 17692415
[TBL] [Abstract][Full Text] [Related]
30. New and emerging strategies in platelet-rich plasma application in musculoskeletal regenerative procedures: general overview on still open questions and outlook.
Salamanna F; Veronesi F; Maglio M; Della Bella E; Sartori M; Fini M
Biomed Res Int; 2015; 2015():846045. PubMed ID: 26075269
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions.
Wang J; Liao L; Tan J
Expert Opin Biol Ther; 2011 Jul; 11(7):893-909. PubMed ID: 21449634
[TBL] [Abstract][Full Text] [Related]
32. A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies.
Warnke PH; Humpe A; Strunk D; Stephens S; Warnke F; Wiltfang J; Schallmoser K; Alamein M; Bourke R; Heiner P; Liu Q
J Craniomaxillofac Surg; 2013 Mar; 41(2):153-61. PubMed ID: 22878221
[TBL] [Abstract][Full Text] [Related]
33. Human mesenchymal stem cells: a bank perspective on the isolation, characterization and potential of alternative sources for the regeneration of musculoskeletal tissues.
Moroni L; Fornasari PM
J Cell Physiol; 2013 Apr; 228(4):680-7. PubMed ID: 22949310
[TBL] [Abstract][Full Text] [Related]
34. Regeneration of articular cartilage by adipose tissue derived mesenchymal stem cells: perspectives from stem cell biology and molecular medicine.
Wu L; Cai X; Zhang S; Karperien M; Lin Y
J Cell Physiol; 2013 May; 228(5):938-44. PubMed ID: 23042088
[TBL] [Abstract][Full Text] [Related]
35. Tracheal regeneration: evidence of bone marrow mesenchymal stem cell involvement.
Seguin A; Baccari S; Holder-Espinasse M; Bruneval P; Carpentier A; Taylor DA; Martinod E
J Thorac Cardiovasc Surg; 2013 May; 145(5):1297-1304.e2. PubMed ID: 23111025
[TBL] [Abstract][Full Text] [Related]
36. Self-assembling peptide nanofiber scaffolds, platelet-rich plasma, and mesenchymal stem cells for injectable bone regeneration with tissue engineering.
Yoshimi R; Yamada Y; Ito K; Nakamura S; Abe A; Nagasaka T; Okabe K; Kohgo T; Baba S; Ueda M
J Craniofac Surg; 2009 Sep; 20(5):1523-30. PubMed ID: 19816290
[TBL] [Abstract][Full Text] [Related]
37. Mouse Flk-1+Sca-1- mesenchymal stem cells: functional plasticity in vitro and immunoregulation in vivo.
Xishan Z; Haojun Y; Baoxin H; Xinna Z; Ni J; Hongmei Z; Xiaoli W; Jun R
Transplantation; 2014 Mar; 97(5):509-17. PubMed ID: 24487394
[TBL] [Abstract][Full Text] [Related]
38. [Regenerative therapy for tendon and ligament disorders in horses. Terminology, production, biologic potential and in vitro effects].
Geburek F; Stadler P
Tierarztl Prax Ausg G Grosstiere Nutztiere; 2011; 39(6):373-83. PubMed ID: 22167082
[TBL] [Abstract][Full Text] [Related]
39. Stem cells combined with bone graft substitutes in skeletal tissue engineering.
Gamie Z; Tran GT; Vyzas G; Korres N; Heliotis M; Mantalaris A; Tsiridis E
Expert Opin Biol Ther; 2012 Jun; 12(6):713-29. PubMed ID: 22500826
[TBL] [Abstract][Full Text] [Related]
40. Dermal matrix scaffold engineered with adult mesenchymal stem cells and platelet-rich plasma as a potential tool for tissue repair and regeneration.
Formigli L; Benvenuti S; Mercatelli R; Quercioli F; Tani A; Mirabella C; Dama A; Saccardi R; Mazzanti B; Cellai I; Zecchi-Orlandini S
J Tissue Eng Regen Med; 2012 Feb; 6(2):125-34. PubMed ID: 21351374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
